Related Articles
Effective introduction of T cell costimulatory molecules into virus modified tumor cell vaccines by modification with bispecific antibodies
Characteristics of a potent tumor vaccine-induced secondary anti-tumor T cell response
AUGMENTATION OF PROTECTIVE IMMUNOTHERAPY AGAINST METASTATIC ESB LYMPHOMA-CELLS BY COMBINING IMMUNE CELL TRANSFER WITH HOST IRRADIATION, ANTIGEN RESTIMULATION AND/OR ANTI-TNF-ALPHA ANTIBODY TREATMENT
Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2
ADOPTIVE TRANSFER OF PROTECTIVE IMMUNITY AGAINST A HIGH METASTATIC TUMOR-CELL VARIANT BY SMALL NUMBERS OF TUMOR-SPECIFIC IN-SITU ACTIVATED PERITONEAL EFFECTOR T-CELLS